Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Aug 10, 2020 10:22am
128 Views
Post# 31386988

RE:and i counter your 12 posts/day with 1, this one:

RE:and i counter your 12 posts/day with 1, this one:Checkpoints completed Sept 2019, 6 months of testing brings us to February 2020.

What is the reason for the BLA not being submitted, its been another 6 months and still nothing.  

You also seem to be stuck on 5,000 doses of administered Ryplazim for months now.  Care to explain?


Newcamo wrote: Lets see who wins in the end:)They added the checkpoints, the plant is set. Liminal went through 6 months of CMC testing at their Ryplazim manufacturing plant as part of BLA after years and years of producing in Laval for over 5000 doses of administered Ryplazim.



<< Previous
Bullboard Posts
Next >>